These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 31415354)
1. Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma. Wong CK; Chan SC; Ng SH; Hsieh CH; Cheng NM; Yen TC; Liao CT Medicine (Baltimore); 2019 Aug; 98(33):e16608. PubMed ID: 31415354 [TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889 [TBL] [Abstract][Full Text] [Related]
3. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of Kim SY; Crook D; Rosskopf J; Lee JH Head Neck; 2024 Sep; 46(9):2284-2291. PubMed ID: 38712471 [TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Ng SH; Lin CY; Chan SC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Huang SF; Lin YC; Wang JJ PLoS One; 2013; 8(8):e72230. PubMed ID: 23951300 [TBL] [Abstract][Full Text] [Related]
7. Multiparametric functional MRI and Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas. Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392 [TBL] [Abstract][Full Text] [Related]
9. Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to prevertebral space. Meerwein CM; Pizzuto DA; Vital D; Morand GB; Stolzmann P; Huber GF; Huellner MW Head Neck; 2019 Feb; 41(2):503-510. PubMed ID: 30561113 [TBL] [Abstract][Full Text] [Related]
10. Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer. Oh JS; Kang BC; Roh JL; Kim JS; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Aug; 22(8):2746-54. PubMed ID: 25487968 [TBL] [Abstract][Full Text] [Related]
11. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma. Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030 [TBL] [Abstract][Full Text] [Related]
12. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma. Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352 [TBL] [Abstract][Full Text] [Related]
13. Combing MRI Perfusion and Chan SC; Yeh CH; Chang JT; Chang KP; Wang JH; Ng SH Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33800542 [TBL] [Abstract][Full Text] [Related]
14. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus. Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of Yu CW; Chen XJ; Lin YH; Tseng YH; Lu CC; Chen BB; Wei SY; Lee JM; Shih TT Eur J Radiol; 2019 Nov; 120():108671. PubMed ID: 31629121 [TBL] [Abstract][Full Text] [Related]
17. Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET. Jansen JF; Schöder H; Lee NY; Stambuk HE; Wang Y; Fury MG; Patel SG; Pfister DG; Shah JP; Koutcher JA; Shukla-Dave A Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):299-307. PubMed ID: 21236594 [TBL] [Abstract][Full Text] [Related]
18. Correlation between apparent diffusion coefficients and metabolic parameters in hypopharyngeal squamous cell carcinoma: A prospective study with integrated PET/MRI. Zhang L; Song T; Meng Z; Huang C; Chen X; Lu J; Xian J Eur J Radiol; 2020 Aug; 129():109070. PubMed ID: 32454330 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma. Calles-Sastre L; Mucientes-Rasilla J; San-Frutos Llorente LM; Royuela A; Garcia-Espantaleón Navas M; Herrero Gámiz S; Pérez-Medina T Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):17-21. PubMed ID: 30366731 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]